Phages plus antibiotics for heart infection treatment
Treatments studied
Part of Heart & circulation, Infections clinical trials.
This trial tests if adding bacteriophages (viruses that kill bacteria) to standard antibiotic treatment can help people with a serious heart valve infection called infective endocarditis. It may offer a new way to fight the infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a current, active heart valve infection (infective endocarditis) diagnosed in or out of the hospital.
- Your infection meets the modified Duke 2023 criteria or is treated as endocarditis by your doctor.
- You are willing and able to give informed consent to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study gathers information from patients with a heart infection called endocarditis to help doctors better understand and treat the condition. Anyone aged 16 or older with confirmed or suspected endocarditis who is being treated at Barts Heart Centre may be able to join.
This study looks at whether taking antibiotics before certain dental procedures helps prevent a serious heart infection in people who have a prosthetic heart valve or have had a heart infection before. It aims to find out if this common practice is effective.
This study tests a new way to find the cause of infective endocarditis, a serious heart infection. It may help doctors choose the right treatment faster.
This trial compares taking antibiotics by mouth versus receiving antibiotics through a vein (outpatient IV) for an infection of the heart valve. It’s designed to see whether the oral option can work as well and safely, especially after initial treatment and surgery if needed.
This trial tests whether a treatment without rifampin works as well as one with rifampin for a type of heart valve infection caused by staph bacteria. It aims to find a simpler and safer option for patients with an infected artificial heart valve.
This study collects blood samples and medical information from patients with certain bloodstream infections to better understand why some develop a heart valve infection. The goal is to find out why some people get this complication and how to predict it.
Hear when a new Endocarditis, Bacterial trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.